Efficacy and Safety of Cryoballoon Ablation in Patients With Heart Failure and Reduced Left Ventricular Ejection Fraction A Multicenter Study

Heeger C., Abdin A., Mathew S., Reissmann B., YALIN K., Liosis S., ...Daha Fazla

CIRCULATION JOURNAL, cilt.83, sa.8, ss.1653-1659, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 83 Sayı: 8
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1253/circj.cj-19-0151
  • Dergi Adı: CIRCULATION JOURNAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1653-1659
  • Anahtar Kelimeler: Atrial fibrillation, Cryoballoon, Heart failure, Long-term outcome, Pulmonary vein isolation, PERSISTENT ATRIAL-FIBRILLATION, 2013 ACCF/AHA GUIDELINE, ASSOCIATION TASK-FORCE, CATHETER ABLATION, 2ND-GENERATION CRYOBALLOON, RADIOFREQUENCY ABLATION, AMERICAN-COLLEGE, SINGLE-CENTER, MANAGEMENT, COMPLICATIONS
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır

Özet

Background: Second-generation cryoballoon (CB2)-based pulmonary vein isolation (PVI) has demonstrated encouraging results in the treatment of atrial fibrillation (AF). This study sought to assess data on the safety, efficacy and clinical success of CB2-based PVI in patients with heart failure (HF) and reduced ejection fraction (HFrEF).